Fund Holdings — Omega Fund Management, LLC

Total Portfolio Value:
$160.01M
Total Bought:
$56.15M
Total Sold:
$15.99M
Net Transaction:
+$40.17M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Bicara Therapeutics Inc.02,204,650+2,204,650$0$56.15M35.09%+$56.15M
Nuvation Bio Inc.CL A(NUVB)13,275,88413,072,340-203,544$38.77M$29.94M18.71%-$8.83M
Replimune Group, Inc.(REPL)2,461,3192,461,3190$22.15M$26.98M16.86%+$4.82M
Lexeo Therapeutics, Inc.(LXEO)2,355,9042,355,9040$37.79M$21.30M13.31%-$16.49M
enGene Holdings Inc.
COM
1,076,3571,076,3570$10.15M$7.10M4.44%-$3.05M
Alumis Inc653,225653,223-2$8.69M$6.98M4.36%-$1.71M
Ikena Oncology2,249,1232,249,1230$3.71M$3.89M2.43%+$179.9K
Sana Biotechnology, Inc.(SANA)843,750843,7500$4.61M$3.51M2.19%-$1.10M
Immunic, Inc.(IMUX)1,788,1601,788,1600$1.98M$2.95M1.84%+$965.6K
enGene Holdings Inc.WARRANT
*W EXP 10/31/202
321,502321,5020$382.6K$675.2K0.42%+$292.6K
Syros Pharmaceuticals251,270251,2700$1.30M$540.2K0.34%-$756.3K
Morphic Holding159,8460-159,846$5.45M$0—-$5.45M
Page 1 of 1
Omega Fund Management, LLC — 13F Holdings — Q3 2024 | TickerTrail